Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/Accurin> ?p ?o }
Showing triples 1 to 26 of
26
with 100 triples per page.
- Accurin abstract "An Accurin(tm) is a type of nanomedicine being developed by Bind Therapeutics to treat various types of cancer.Accurins include: BIND-014, targeting PSMA delivering docetaxel, in phase 2 clinical trials BIND-510, targeting PSMA delivering vincristine. IND soon. BIND-2206 containing the AKT inhibitor MK-2206.↑ 1.0 1.1 ↑ 2.0 2.1".
- Accurin wikiPageID "48525887".
- Accurin wikiPageLength "1138".
- Accurin wikiPageOutDegree "12".
- Accurin wikiPageRevisionID "704199662".
- Accurin wikiPageWikiLink BIND-014.
- Accurin wikiPageWikiLink BIND-2206.
- Accurin wikiPageWikiLink BIND-510.
- Accurin wikiPageWikiLink Bind_Therapeutics.
- Accurin wikiPageWikiLink Category:Nanomedicine.
- Accurin wikiPageWikiLink Docetaxel.
- Accurin wikiPageWikiLink Glutamate_carboxypeptidase_II.
- Accurin wikiPageWikiLink Investigational_New_Drug.
- Accurin wikiPageWikiLink MK-2206.
- Accurin wikiPageWikiLink Nanomedicine.
- Accurin wikiPageWikiLink Protein_kinase_B.
- Accurin wikiPageWikiLink Vincristine.
- Accurin wikiPageWikiLinkText "Accurin".
- Accurin wikiPageUsesTemplate Template:Reflist.
- Accurin wikiPageUsesTemplate Template:Treatment-stub.
- Accurin subject Category:Nanomedicine.
- Accurin hypernym Nanomedicine.
- Accurin comment "An Accurin(tm) is a type of nanomedicine being developed by Bind Therapeutics to treat various types of cancer.Accurins include: BIND-014, targeting PSMA delivering docetaxel, in phase 2 clinical trials BIND-510, targeting PSMA delivering vincristine. IND soon. BIND-2206 containing the AKT inhibitor MK-2206.↑ 1.0 1.1 ↑ 2.0 2.1".
- Accurin label "Accurin".
- Accurin wasDerivedFrom Accurin?oldid=704199662.
- Accurin isPrimaryTopicOf Accurin.